: Richard A. Watts, David G. I. Scott
: Richard Watts, David G. I. Scott
: Vasculitis in Clinical Practice
: Springer-Verlag
: 9781849962476
: 1
: CHF 44.60
:
: Klinische Fächer
: English
: 193
: DRM
: PC/MAC/eReader/Tablet
: PDF
The systemic vasculitides are a group of disorders which are of increasing importance. Many of these conditions are only rarely encountered by general physicians and often present significant diagnostic challenges. Our goal in writing this short book was to provide easily accessible information in a pocket-sized format. We hope we have helped both the g- eral rheumatologist who only encounter these problems occasionally. We have focused on clinical presentation, di- nostic processes, and current management. We hope, the- fore, that we will help our patients with these potentially devastating conditions by improving diagnosis and therapy. Richard A. Watts Ipswich, UK David G. I. Scott Norwich, UK v Contents Part I Introduction 1 Defnitions 3 1 1 General Introduction 3 1 2 Defnitions 4 2 Classifcation and Epidemiology 7 2 1 Introduction 7 2 2 ACR (1990) Criteria 8 2 3 Chapel Hill Consensus Defnitions 9 2 4 Epidemiology 9 2 5 Etiological Factors 10 References 11 3 General Presentation of the Vasculitides 13 3 1 Introduction 13 3 2 Pattern Recognition 13 3 3 Laboratory Investigations 16 3 4 Differential Diagnosis 18 References 19 4 General Principles of Treatment 21 4 1 Treatment 21 4 2 Remission Induction 21 4. 2. 1 Large Vessel Disease . . . . . . . . . . . . . . 22 4. 2. 2 Medium Vessel Disease . . . . . . . . . . . . 22 4. 2. 3 Medium/Small Vessel Vasculitis . . . . . 22 4. 2. 4 Small Vessel Vasculitis . . . . . . . . . . . . .

Richard A. Watts, DM MA FRCP is a Senior Lecturer at the University of East Anglia School of Medicine, Health and Policy Practice and a Consultant Rheumatologist at Ipswich Hospital NHS Trust, in the UK.David G.I. Scott, MD FRCP is a Consultant Rheumatologist at Norfolk and Norwich University Hospital NHS Trust, and an Honorary Professor at the University of East Anglia, School of Medicine, Health Policy and Practice, in the UK.
Vasculitis in Clinical Practice2
Preface4
Contents5
Contributors16
Abbreviations17
Part 1: Introduction19
Chapter 1: Definitions20
1.1 General Introduction20
1.2 Definitions21
Chapter 2: Classification and Epidemiology24
2.1 Introduction24
2.2 ACR (1990) Criteria25
2.3 Chapel Hill Consensus Definitions26
2.4 Epidemiology26
2.5 Etiological Factors27
Key Points28
References28
Chapter 3: General Presentation of the Vasculitides29
3.1 Introduction29
3.2 Pattern Recognition29
3.3 Laboratory Investigations32
3.4 Differential Diagnosis34
Key Points34
References35
Chapter 4: General Principles of Treatment36
4.1 Treatment36
4.2 Remission Induction36
4.2.1 Large Vessel Disease37
4.2.2 Medium Vessel Disease37
4.2.3 Medium/Small Vessel Vasculitis37
4.2.4 Small Vessel Vasculitis39
4.3 Maintenance Therapy40
4.4 Long-Term Follow-Up40
4.5 Relapsing Disease40
4.6 Refractory Disease41
4.7 Specific Drugs Used to Treat Vasculitis42
4.7.1 Cyclophosphamide42
4.7.2 Glucocorticoids43
4.7.3 Methotrexate43
4.7.4 Plasma Exchange44
4.8 Monitoring44
4.9 Patient Advice45
4.10 Detection and Prevention of the Adverse Effects of Therapy45
4.10.1 Osteoporosis45
4.10.2 Vaccinations46
4.10.3 Pneumocystis Jirovecii Infection46
4.10.4 Cyclophosphamide-Induced Bladder Toxicity46
Key Points46
References47
Part 2: Features of Individual Diseases48
Chapter 5: Giant Cell Arteritis49
5.1 Introduction49
5.2 Definition and Classification49
5.3 Epidemiology50
5.4 Etiology50
5.5 Clinical Features51
5.5.1 Systemic51
5.5.2 Craniofacial51
5.5.3 Ophthalmic53
5.5.4 Neurologic53
5.5.5 Extracranial Artery53